TANDEM DIABETES CARE INC (TNDM) Stock Analyst Ratings
NASDAQ:TNDM - US8753722037 - Common Stock
12.24 USD
+0.13 (+1.07%)
12.39 USD
+0.15 (+1.23%)
ChartMill assigns a Buy % Consensus number of 72% to TNDM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.75. This target is 85.85% above the current price.
TNDM was analyzed by 30 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about TNDM.
In the previous month the buy percentage consensus was at a similar level.
TNDM was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-08-12 | Citigroup | Upgrade | Sell -> Neutral |
| 2025-08-11 | Lake Street | Downgrade | Buy -> Hold |
| 2025-08-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-07 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-07-09 | Citigroup | Downgrade | Neutral -> Sell |
| 2025-06-16 | Truist Securities | Initiate | Hold |
| 2025-05-22 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-05-01 | Stifel | Maintains | Buy -> Buy |
| 2025-05-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-01 | Baird | Maintains | Neutral -> Neutral |
| 2025-05-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-10 | Mizuho | Initiate | Neutral |
| 2025-03-05 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-03-04 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-03-03 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-03-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-27 | Baird | Maintains | Neutral -> Neutral |
| 2025-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-12-11 | Citigroup | Maintains | Buy -> Buy |
| 2024-12-02 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-11-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-07 | Baird | Maintains | Neutral -> Neutral |